The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

Two of the world's largest pharmaceutical companies are suing Oklahoma to stop a new state law dealing with a $70 billion ...

Ozempic can help manage type 2 diabetes, but it's also becoming increasingly popular for weight loss, which is an off-label use. Clinical trials show that Ozempic's active ingredient, semaglutide ...

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

The measure extending tax cuts and slashing the social safety net goes to President Trump for his signature, but the debate ...

First Reading is a Canadian politics newsletter curated by the National Post’s own Tristin Hopper. To get an early version ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

There are several reasons why switching to a new Medicare Part D plan is a smart move. A good Part D prescription drug plan covers what you need to stay healthy without breaking the bank.

Former Senate HELP ranker Richard Burr has pulled in yet another new lobbying client from the pharmaceuticals world.

Dive Insight: The Center for Medicare and Medicaid Innovation will oversee WISeR, which will run for six years, between Jan. 1, 2026, and Dec. 31, 2031.